Microfluidics Market to Experience Substantial Growth of 70.93 Billion by 2030, Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis

Data Bridge Market Research analyses that the microfluidics market which was USD 23.17 billion in 2022, is expected to reach USD 70.93 billion by 2030, at a CAGR of 15.01% during the forecast period 2023 to 2030.


Montréal , April 13, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Microfluidics Market" with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy-to-grasp full analysis. The universal Microfluidics business report encompasses a thorough study of the current situation of the global market along with several market dynamics Competitor analysis is one of the most important aspects of a market research report which helps businesses decide upon strategies by comparing them with the competitors. The use of the newest and most advanced tools and techniques used for this report makes it the finest in the class. Competitor strategies highlighted in the winning Microfluidics market survey report mainly include new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost their footprints in this market.

Data Bridge Market Research analyses that the microfluidics market, which was USD 23.17 billion in 2022, is expected to reach USD 70.93 billion by 2030, at a CAGR of 15.01% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Obtain a PDF Sample of the Microfluidics Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microfluidics-market

Microfluidics is a technological method used to investigate the nature and characteristics of fluids. Its application entails the use of a set of tools for manipulating and controlling the chemical and biological processes of small volumes of fluids. It is also used in the production of microminiaturized devices with numerous tunnels and chambers through which fluids flow or are confined. In comparison to traditional fluid measuring devices, it requires fewer samples, the tools are smaller, and it provides excellent parameter control and data quality. As a result, it's commonly used for DNA analysis, cell separation and manipulation, and PCR amplification.

According to GLOBOCAN 2020, there were 19,282,789 new cancer cases worldwide in 2020, with a projected increase to 28,887,940 cases by 2040. As a result, global cancer incidence and modern healthcare facilities have been major drivers of market growth. ​​Furthermore, market participants have broadened their diagnostic platforms to include POC on microfluidic devices. As a result of the expansion of the range of POC diagnostics, there will be a significant expansion in microfluidics, which may enable the development of new devices

Opportunities

  • Development of new products

In March 2021, the Loschmidt laboratories team collaborated with ETH Zurich partners to create a microfluidic platform to effectively and rapidly investigate enzymes and their properties. The novel platform was already being used to develop new thrombolytics for stroke treatment and to study the evolution of bioluminescent enzymes. Furthermore, in November 2019, Panasonic Corporation and IMT collaborated to develop a technology for mass production of microfluidic devices using glass molding. When compared to traditional glass etching techniques, this technology employs low-cost, high-accuracy mass production. These devices can be used for analysis and sensing in biological, environmental, and medical applications, and thus are expected to drive the microfluidics market during the forecast period.

Fundamental Aim of Microfluidics Market Report

In the Microfluidics market, every company has goals, but this report focus in on the most important ones, allowing you to gain insight into the competition, the future of the market, potential new products, and other useful information that can boost your sales significantly.

  • Major alterations to the Microfluidics Market in the near future.
  • Notable Market rivals around the world.
  • The Microfluidics Market's Future Scope and Product Outlook
  • Future-promising emerging markets.
  • The Market Presents Difficult Challenges and Threats.
  • Sales data and profiles of the world's leading Microfluidics Players

The Microfluidics Market is Dominated by Firms Such as

  • Danaher (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Agilent Technologies Inc. (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • BD (U.S.)
  • Illumina, Inc. (U.S.)
  • F. Hoffmann-La Roche (Switzerland)
  • Fluidigm Corporation (U.S.)
  • Dolomite Microfluidics (U.K.)
  • QIAGEN (Germany)
  • Abbott (U.S.)
  • BIOMÉRIEUX (France)
  • microfluidic ChipShop GmbH (Germany)
  • Elveflow (France)
  • Cellix Bio. (India)
  • Micronit B.V. (Netherlands)
  • PARKER HANNIFIN CORP (U.S.)
  • Fortive (U.S.)

Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-microfluidics-market

Recent Development

  • In 2021, Fluidigm launched its new Biomark X microfluidics platform. Biomark X streamlines operations to reduce hands-on time and speeds up results with more data per run.
  • In 2021, SCHOTT agreed to buy Applied Microarrays Inc., a microarray solutions company based in Arizona. This will strengthen the company's presence in the United States as well as its bioscience capabilities.

Key Market Segments Covered in Microfluidics Industry Research

Product Type

  • Microfluidic-based devices
  • Microfluidic Components
  • Microfluidic chips
  • Flow and pressure sensors
  • Flow and pressure controllers
  • Microfluidic valves
  • Micropumps
  • Microneedles
  • Components

 Material

  • Polymer
  • Glass
  • Silicon
  • Metal
  • PDMS
  • Other

 Technology

  • Medical/Healthcare
  • Non-medical

 Application

  • In Vitro diagnostics
  • Clinical diagnostics
  •  Point-of-care testing
  •  Veterinary diagnostics
  • Point-of-Care Testing
  • Clinical Diagnostics
  • Pharmaceutical Research
  • Lab Analytics
  • Proteomics
  • Genomics
  • Cell-based assays
  • Capillary electrophoresis
  • Microdispensing
  • Microreaction
  • Drug Delivery
  • Laboratory Testing
  • Analytical Testing
  • High Throughput Screening

 Sector

  • Industrial
  • Healthcare
  • In-vitro Diagnostics
  • Environmental Research
  • Clinical Diagnostics

 End User

  • Hospitals and Diagnostic Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

Key Growth Drivers:

  • Increased demand for microfluidics tools

The global increase in COVID-19 cases has increased the demand for microfluidics tools. PCR is used in many approved tests, making it a preferred technique for COVID-19 diagnosis. To combat the increasing number of COVID-19 cases worldwide, several manufacturers have introduced products and increased production to meet the growing demand for IVD tests. When combined with microfluidics, the PCR technique can be accelerated, resulting in faster test results with high accuracy (from approximately 1 hour to less than 10 minutes). For instance, BeforCure, an Elvesys spin-off company, developed an ultra-fast PCR-on-chip system for virus detection. This product is based on Fastgen technology and takes advantage of microfluidics to provide test results in less than 30 minutes. Moreover, several studies are being conducted to evaluate the use of microfluidics in COVID-19 detection via PCR. These are the certain factors which help the market to grow.

  • Rise in demand of Point-of-care diagnostics (POC)

Point-of-care diagnostics (POC) is believed to be an important part of healthcare, particularly in disease diagnosis. Microfluidics technology is ideal for point-of-care diagnostics. This technology has the potential to provide rapid and affordable point-of-care diagnostic tools to aid in the COVID-19 pandemic. The demand for point-of-care molecular diagnostics is expected to increase in the future because point-of-care diagnostics enable the early detection of disease,

Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-microfluidics-market

Microfluidics Market Regional Analysis/Insights:

The countries covered in the microfluidics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the microfluidics market due to research institutions' extensive involvement in the development of novel microfluidic devices

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the government's increased support for developed infrastructure and robust intellectual property ownership

This Market Intelligence Report Analyses Some of the Most Crucial Concerns:

  • How will the major segments of this international market develop over the next few years?
  • Who are the major players that will dominate the market in the future?
  • When it comes to this industry, who are the top suppliers and producers?
  • How have the most successful companies in the industry planned for future growth and expansion?
  • In what sectors might we expect to see the greatest increase in demand over the coming years?
  • How many distinct subsets of buyers make up this market?
  • Which regional powerhouse do you foresee as becoming the largest player in the international market?
  • Does a new coronavirus pandemic have any consequences?
  • In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Microfluidics Market: Regulations
  6. Market Overview
  7. Global Microfluidics Market, By Product Type
  8. Global Microfluidics Market, By Material
  9. Global Microfluidics Market, By Technology
  10. Global Microfluidics Market, By Application
  11. Global Microfluidics Market, By Sector
  12. Global Microfluidics Market, By End User
  13. Global Microfluidics Market, By Region
  14. Global Microfluidics Market: Company Landscape
  15. SWOT Analyses
  16. Company Profile
  17. Questionnaires
  18. Related Reports

Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-microfluidics-market

Explore More Reports:

North America Microfluidics Market, By Product Type (Microfluidic-based devices and Microfluidic Components), Material (Polymer, Glass, Silicon, Other), Application (In Vitro diagnostics, Point-of-Care Testing, Clinical Diagnostics, Pharmaceutical Research, Lab Analytics, Microdispensing, Microreaction, Drug Delivery, Laboratory Testing, High Throughput Screening), Sector (Industrial, Healthcare), End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/north-america-microfluidics-market

Europe Microfluidics Market, By Product Type (Microfluidic-based devices and Microfluidic Components), Material (Polymer, Glass, Silicon, Other), Application (In Vitro diagnostics, Point-of-Care Testing, Clinical Diagnostics, Pharmaceutical Research, Lab Analytics, Microdispensing, Microreaction, Drug Delivery, Laboratory Testing, High Throughput Screening), Sector (Industrial, Healthcare), End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia and Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-microfluidics-market

Asia-Pacific Microfluidics Market, By Product Type (Microfluidic-based devices and Microfluidic Components), Material (Polymer, Glass, Silicon, Other), Application (In Vitro diagnostics, Point-of-Care Testing, Clinical Diagnostics, Pharmaceutical Research, Lab Analytics, Microdispensing, Microreaction, Drug Delivery, Laboratory Testing, High Throughput Screening), Sector (Industrial, Healthcare), End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific) Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/asia-pacific-microfluidics-market

Medical Aesthetics Market, By Product Type (Aesthetic Laser Devices, Energy Devices, Body Contouring Devices, Facial Aesthetic Devices, Aesthetic Implants, and Skin Aesthetic Devices), Application (Anti-Aging and Wrinkles, Facial and Skin Rejuvenation, Breast Enhancement, Body Shaping and Cellulite, Tattoo Removal, Vascular Lesions, Sears, Pigment Lesions, Reconstructive, Psoriasis, and Vitiligo and Others), End User (Cosmetic Centers, Dermatology Clinics, Hospitals, Medical Spas, and Beauty Centers), Distribution Channel (Direct Tender and Retail Sales) https://www.databridgemarketresearch.com/reports/global-medical-aesthetics-market

Biopharmaceuticals Market, By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other) https://www.databridgemarketresearch.com/reports/global-biopharmaceuticals-market

Sleep Apnea Devices Market, By Diseases Type (Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome), Type (Devices, Therapy), Patient Demographics (Pediatric, Adult, Geriatric), End User (Hospital/ Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Centers, Home Healthcare), Distribution Channel (Direct Tender, Retail Sales) https://www.databridgemarketresearch.com/reports/global-sleep-apnea-devices-market

Probiotics Market, By Form (Liquid, Dry), Ingredient (Bacteria, Yeast), Application (Functional Food and Beverages, Dietary Supplements, Animal Feed), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores, Online), End User (Human, Animal) https://www.databridgemarketresearch.com/reports/global-probiotics-market

Gene Synthesis Market, By Component (Synthesizer, Consumables, and Software & Services), Gene Type (Standard Gene, Express Gene, Complex Gene and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutics Antibodies, and Others), Method (Solid Phase Synthesis, Chip-Based DNA Synthesis, and PCR-Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostics Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distributors) https://www.databridgemarketresearch.com/reports/global-gene-synthesis-market

Telehealth Market, By Type (Software, Systems, Hardware, Telecommunication) Delivery Mode (Cloud-Based Delivery Mode, Web-Based Delivery Mode, On-Premise Delivery Mode) Application (General Consultation, Pathology, Cardiology, Surgery, Gynecology, Neurology, Radiology, Dermatology, Ophthalmology, Orthopedics, Others) End User (Hospital Telehealth, Physician Telehealth, Home Telehealth) https://www.databridgemarketresearch.com/reports/global-telehealth-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com